Market statusUnder Development

Products 81 to 90 of 119

Biotech components: Gene Editing
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government + Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 1,650,980 USD
Funding types: Venture Capital
Industry: Food & Agriculture + Security
Market status: Under Development
Organization type(s): Private Company
Product categories: Design + Food + Threat detection
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
ON Technology by Pivot Bio
Biotech components: Microbe
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:36 (5 years ago)
Known funding amount: 16,700,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Soil Amendment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Optisochem by Bio Based Industry- Joint Undertaking (BBI-JU)
Biotech components: Enzyme + Yeast
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (5 years ago)
Date last modified: 2019/09/12 15:10 (5 years ago)
Known funding amount: 16,376,817 EUR
Funding types: Government + Private Funding
Industry: Energy + Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Orb by BIOHM
Biotech components: Fungus + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: N/A
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:35 (3 years ago)
Date last modified: 2020/12/18 14:35 (3 years ago)
Known funding amount: 2,687,657 EUR
Funding types: Government
Industry: Industrial
Market status: Under Development
Organization type(s): Research Institution
Product categories: Other
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input + Platform
Biotech components: Fungus + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (5 years ago)
Date last modified: 2018/11/19 09:36 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction + Design
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Plant-Based Pork by Impossible Foods
Biotech components: Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:56 (4 years ago)
Date last modified: 2020/02/10 09:56 (4 years ago)
Known funding amount: 687,500,000 USD
Funding types: Private Funding + Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:34 (3 years ago)
Date last modified: 2020/12/18 14:34 (3 years ago)
Known funding amount: 3,200,000
Funding types: Foundation + Private Funding
Industry: Industrial + Multipurpose + Novelty
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction + Design + Other
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input + Platform
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:53 (5 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (5 years ago)
Date last modified: 2019/09/12 14:31 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product